Clinical Trial Update: ICC-1132 - Candidate Vaccine Against P Falciparum Malaria [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing completion of Phase 1 testing for ICC-1132, a vaccine candidate targeting Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• ICC-1132 vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED